Latest News and Press Releases

DISCO Pharmaceuticals appoints biotech leader Mark Manfredi as CEO and raises €36M to advance surfaceome-targeted ADC therapies for hard-to-treat tumors

Abalos to present preclinical data on ABX-001 and its potential to further intensify anti-tumoral effects when combined with bispecific T-cell engagers